GeneDx Holdings Corp. (WGS) NASDAQ

118.26

+0.89(+0.76%)

Updated at October 03 04:00PM

Currency In USD

Valuation

Market Cap2.07B
Enterprise Value2.1B
P/E Ratio2,453.46
PEG Ratio23.87
Price/Sales Ratio9.57
Price/Book Ratio12.45
Enterprise/Revenue9.54
Enterprise/EBITDA151.31

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0
Operating Margin0.02

Management Effectiveness

Return On Assets0
Return On Equity0.01

Income Statement

Revenue305.45M
Revenue/Share12.68
Gross Profit194.4M
EBITDA-27.64M
Net Income-52.29M
Diluted EPS-1.94

Balance Sheet

Total Cash134.56M
Total Cash/Share4.71
Total Debt62.7M
Total Debt/Equity0.23
Current Ratio2.87
Book Value Per Share9.7

Price History

52-Week Change156.18
52-Week High136
52-Week Low46.62
Moving Average 50 Days117.09
Moving Average 200 Days91.03

Statistics

Average Volume731,295
Shares Outstanding28.73M
% Held by Institutions102.34

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:33
Last Split DateMay 04, 2023